Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation

Abstract

Osteoporotic fractures are potential long-term complications of bone marrow transplantation (BMT). We previously reported that bone mineral density (BMD) of patients undergoing allogeneic BMT decreased by 6% to 9% during the first 6 months after BMT and that bone turnover rate was still increased 1 year after BMT. BMT patients do not need lifelong immunosuppressive treatment, which should offer favorable circumstances for the recovery of BMD. Thus, 27 (14 women, 13 men) of 29 long-term survivors of our previous study were invited to a follow-up study at a median of 75 months after BMT. From 12 months after BMT the BMD of the lumbar spine had increased by 2.4% (P = 0.002). The respective changes in femoral sites were +4.1% in the femoral neck (P = 0.087), 4.0% in the trochanter (P = 0.095), +4.7% in Ward's triangle (P = 0.072) and +1.4% in the total hip (P = 0.23). The markers of bone formation, serum osteocalcin and type I procollagen aminoterminal propeptide (PINP) had returned to control levels, but out of the markers of bone resorption the mean level of serum type I carboxyterminal telopeptide (ICTP) was 41% higher (P = 0.0001) and that of urinary type I collagen N-terminal telopeptide/creatinine (NTx) 41% lower (P = 0.0002) in patients than in controls. The mean serum 25-hydroxyvitamin D [25(OH)D] was 33% lower in patients (P = 0.0002), most of whom had hypovitaminosis D [serum 25(OH)D 37 nmol/l]. Except for two, males had serum testosterone level lower than before BMT and four men had hypogonadism. In conclusion, in long-term survivors of allogeneic BMT BMD recovers and bone turnover state normalizes as compared to the situation 1 year after BMT. More attention should be paid to the vitamin D status of all recipients and to possible hypogonadism of male patients.

Bone Marrow Transplantation (2002) 29, 33–39. doi:10.1038/sj.bmt.1703317

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Katz IA, Epstein S . Perspectives. Post-transplantation bone disease J Bone Miner Res 1992 7: 123 126

    Article  CAS  Google Scholar 

  2. Välimäki MJ, Kinnunen K, Volin L et al. Prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin Bone Marrow Transplant 1999 23: 355 361

    Article  Google Scholar 

  3. Ebeling PR, Thomas DM, Erbas B et al. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation J Bone Miner Res 1999 14: 342 350

    Article  CAS  Google Scholar 

  4. Kanis JA, Melton LJ, Christiansen C et al. Perspective. The diagnosis of osteoporosis J Bone Miner Res 1994 9: 1137 1141

    Article  CAS  Google Scholar 

  5. Schulte C, Beelen DW, Schaefer UW, Mann K . Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study Osteoporos Int 2000 11: 344 353

    Article  CAS  Google Scholar 

  6. Epstein S . Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton J Bone Miner Res 1996 11: 1 7

    Article  CAS  Google Scholar 

  7. Kellholz U, Max R, Schelbenbogen C et al. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation Cancer 1997 79: 1617 1622

    Article  Google Scholar 

  8. Garnero P, Borel O, Byrjalsen I et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases J Biol Chem 1998 273: 32347 32352

    Article  CAS  Google Scholar 

  9. Atley LM, Mort JS, Lalumiere M, Eyre DR . Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating the cross-linked N-telopeptide neoepitope Bone 2000 26: 241 247

    Article  CAS  Google Scholar 

  10. Sassi M-L, Eriksen H, Risteli L et al. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K Bone 2000 26: 367 373

    Article  CAS  Google Scholar 

  11. Cummings SR, Black DM, Thompson DE et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures – results from the fracture intervention trial JAMA 1998 280: 2077 2082

    Article  CAS  Google Scholar 

  12. Pols HAP, Felsenberg D, Hanley DA et al. Multinational, placebo-controlled, randomised trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT-study Osteoporos Int 1999 9: 461 468

    Article  CAS  Google Scholar 

  13. Adachi JD, Roux C, Pitt PI et al. A pooled data analysis on the use of intermittent etidronate therapy to prevention and treatment of corticosteroid bone loss J Rheumatol 2000 27: 2424 2431

    CAS  PubMed  Google Scholar 

  14. Reid DM, Hughes RA, Laan RF et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomised trial. European corticosteroid-induced osteoporosis treatment study J Bone Miner Res 2000 15: 1006 1013

    Article  CAS  Google Scholar 

  15. Body JJ, Bartl R, Burckhardt P et al. Current use of bisphosphonates in oncology J Clin Oncol 1998 16: 3890 3899

    Article  CAS  Google Scholar 

  16. Shane E, Rodino MA, McMahon DJ et al. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study J Heart Lung Transplant 1998 17: 1089 1096

    CAS  PubMed  Google Scholar 

  17. Christgau S, Bitsch-Jensen O, Hanover Bjarnason N et al. Serum crossLaps for monitoring the response in individuals undergoing antiresorptive therapy Bone 2000 26: 505 511

    Article  CAS  Google Scholar 

  18. Garnero P, Shih WJ, Gineyts E et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment J Clin Endocrinol Metab 1994 79: 1693 1700

    CAS  PubMed  Google Scholar 

  19. Teronen O, Heikkilä P, Konttinen YT et al. MMP inhibition and downregulation by bisphosphonates Ann NY Acad Sci 1999 878: 453 465

    Article  CAS  Google Scholar 

  20. Thomas MK, Lloyd-Jones DM, Thandhani RI et al. Hypovitaminosis D in medical patients New Engl J Med 1998 338: 777 783

    Article  CAS  Google Scholar 

  21. Kauppinen-Mäkelin R, Tähtelä R, Löyttyniemi E et al. A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients J Intern Med 2001 249: 559 563

    Article  Google Scholar 

  22. Kauppila M, Viikari J, Irjala K et al. The hypothalamus–pituitary–gonad axis and testicular function in male patients after treatment for haematological malignancies J Intern Med 1998 244: 411 416

    Article  CAS  Google Scholar 

  23. Rodino MA, Shane E . Osteoporosis after organ transplantation Am J Med 1998 104: 459 469

    Article  CAS  Google Scholar 

  24. Snyder PJ, Peachey H, Berlin JA et al. Effects of testosterone replacement in hypogonadal men J Clin Endocrinol Metab 2000 85: 2670 2677

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Ritva Keskimäki for excellent technical support. The study was supported by a grant from the Erityisvaltionosuus (Grant TYH-9321).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kananen, K., Volin, L., Tähtelä, R. et al. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 29, 33–39 (2002). https://doi.org/10.1038/sj.bmt.1703317

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703317

Keywords

This article is cited by

Search

Quick links